Shanghai Kehua Bio-Engineering Co Ltd002022
▼ NegativeCapitalrelevance
Net loss of 104 million yuan and negative operating cash flow in interim report.
Impact on stocks 1
Others
Shanghai Kehua Bio-Engineering Co LtdKHB released its 2026 interim report, with total operating revenue of 838 million yuan and net profit attributable to the parent company of minus 104 million yuan, ranking 114th among disclosed peer companies. Net cash flow from operating activities was minus 54.4492 million yuan, a decrease of 3.4525 million yuan compared with the same period last year. The company's latest asset-liability ratio was 33.19%, gross margin was 36.73%, ROE was minus 4.12%, and diluted earnings per share was minus 0.20 yuan. The number of shareholders was 43,800, and the top ten shareholders held 24.70% of the total share capital.
Shanghai Kehua Bio-Engineering Co LtdNet loss of 104 million yuan and negative operating cash flow in interim report.